UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term Outcomes of Radical Dose Escalation by High-Dose-Rate Brachytherapy for Localized Prostate Cancer: Comparison of 3 Different Risk Stratifications According D’Amico, Zelefsky, and Kiel Protocol

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E233-E233

2015

Volltextzugriff (PDF)

Superiority of Real-Time Adaptive Interstitial High-Dose-Rate Brachytherapy for Localized Prostate Cancer—Five- and 8-Year Outcomes of Kiel University Hospital Protocols

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E277-E278

2016

Volltextzugriff (PDF)

Radical Dose Escalation by High Dose Rate Brachytherapy for Localized Prostate Cancer: Significance of PSA Nadir Level as a Predictor for Long-term Biochemical Control

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E232-E232

2015

Volltextzugriff (PDF)

PO-0976: HDR prostate brachytherapy: 3-D planned simultaneous integrated boost to the peripheral zone

Radiotherapy and oncology, 2016-04, Vol.119, p.S475-S475

2016

Volltextzugriff (PDF)

PO-1040: Follow-up analysis of combined HDR-brachytherapy and external beam radiotherapy for prostate cancer patients

Radiotherapy and oncology, 2015-04, Vol.115, p.S561-S561

2015

Volltextzugriff (PDF)

High-Dose-Rate Brachytherapy for Radical Dose Escalation in Patients With Localized Prostate Cancer: A Longitudinal Comparative Study of 3 Historical Protocols

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S438-S439

2014

Volltextzugriff (PDF)

Combined High-Dose-Rate (HDR) Brachytherapy and External Beam Radiation Therapy (EBRT) for Prostate Cancer: 5- and 10-Year Outcomes of Protocols 1 Versus 2

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S126-S127

2013

Volltextzugriff (PDF)

PO-232 ARE URETHRAL TOXICITIES CORRELATED WITH DOSE AFTER INTERSTITIAL HDR BOOST BRACHYTHERAPY FOR PROSTATE CANCER?

Radiotherapy and oncology, 2012-05, Vol.103, p.S94-S94

2012

Volltextzugriff (PDF)

Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer

International journal of radiation oncology, biology, physics, 2002, Vol.52 (1), p.81-90

2002

Volltextzugriff (PDF)

PO-1036: Intraoperative HDR brachytherapy and external beam radiotherapy for prostate cancer: long-term outcomes

Radiotherapy and oncology, 2014, Vol.111, p.S158-S159

2014

Volltextzugriff (PDF)

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer

Oncogene, 2006-08, Vol.25 (36), p.4965-4974

2006

Volltextzugriff (PDF)

OC-24 TEN-YEAR OUTCOMES FOR PATIENTS WITH GLEASON 8-10 TREATED WITH HIGH DOSE RATE BRACHYTHERAPY BOOST

Radiotherapy and oncology, 2012-05, Vol.103, p.S10-S10

2012

Volltextzugriff (PDF)

PSMA-PET-Based Salvage By Image-Guided Adaptive HDR-Brachytherapy (HDR-IGABT) for Locally Relapsed Prostate Cancer or Stereotactic Radiation Therapy (SRT) for Distant Oligometastatic Progression – One-Year Outcomes of a Prospective Assessment in 35 Patients

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e111-e111

2018

Volltextzugriff (PDF)

Online Planned TRUS-based HDR Brachytherapy for Localized Prostate Cancer (Pca): Demonstration of a Learning Curve

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S339-S339

2009

Volltextzugriff (PDF)

PO-1033: Activation of specific anti-tumor immunity by alpha radiation based brachytherapy and immunotherapy

Radiotherapy and oncology, 2018-04, Vol.127, p.S580-S581

2018

Volltextzugriff (PDF)

Cure of Triple Negative Breast Cancer Bearing Mice by Intratumoral Diffusion of Alpha-Particle Emitting Atoms in Combination with Cytoplasmic Delivery of PolyIC in a Neoadjuvant Setting

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S126-S126

2019

Volltextzugriff (PDF)

10 Year Radiotherapy Results for Prostate Cancer Patients Harboring Gleason 7-10, Stage ≥T2b, iPSA ≥20: More and Faster is Better

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S296-S296

2008

Volltextzugriff (PDF)

10-year Results in 1577 Intermediate/High Risk Prostate Cancer Patients Treated With External Beam RT (EBRT) and Hypofractionated High Dose Rate (HDR) Brachytherapy Boost

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S83-S84

2007

Volltextzugriff (PDF)

Improved 10-year Outcomes for Prostate Cancer Patients With Gleason 8–10 Treated With Intensity Modulated High Dose Rate Brachytherapy Boost in the PSA Era

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S84-S85

2007

Volltextzugriff (PDF)

2ndconservative Treatment for 2ndipsilateral Breast Tumor Event: Mature Oncological Results and Prognostic Factors from the GEC-Estro Bcwg

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S8-S8

2019

Volltextzugriff (PDF)

Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)

European journal of cancer (1990), 2011-01, Vol.47 (2), p.183-190

2011

Volltextzugriff (PDF)

High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features

Prostate cancer and prostatic diseases, 2006-09, Vol.9 (3), p.245-253

2006

Volltextzugriff (PDF)

Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S80-S80

2018

Volltextzugriff (PDF)

2009 Prevalence of erectile dysfunction in men with prostate cancer (PCa) prior to definitive radiotherapy: a prospective assessment

European journal of cancer supplements, 2009, Vol.7 (2), p.154-154

2009

Volltextzugriff (PDF)

Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer

Strahlentherapie und Onkologie, 1999-06, Vol.175 Suppl 2 (S2), p.87-88

1999

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(88)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Male
(18)
Hematology, Oncology And Palliative Medicine
(16)
Oncology
(15)
Aged
(13)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Middle Aged
(12)
Prostatic Neoplasms - Radiotherapy
(12)
Prostate Cancer
(10)
Biological And Medical Sciences
(9)
Female
(9)
Medical Sciences
(9)
Prostatic Neoplasms - Pathology
(9)
Radiology
(9)
Combined Modality Therapy
(8)
Neoplasm Staging
(8)
Radiotherapy Dosage
(8)
Aged, 80 And Over
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Outcomes of Radical Dose Escalation by High-Dose-Rate Brachytherapy for Localized Prostate Cancer: Comparison of 3 Different Risk Stratifications According D’Amico, Zelefsky, and Kiel Protocol

Superiority of Real-Time Adaptive Interstitial High-Dose-Rate Brachytherapy for Localized Prostate Cancer—Five- and 8-Year Outcomes of Kiel University Hospital Protocols

Radical Dose Escalation by High Dose Rate Brachytherapy for Localized Prostate Cancer: Significance of PSA Nadir Level as a Predictor for Long-term Biochemical Control

PO-0976: HDR prostate brachytherapy: 3-D planned simultaneous integrated boost to the peripheral zone

PO-1040: Follow-up analysis of combined HDR-brachytherapy and external beam radiotherapy for prostate cancer patients

High-Dose-Rate Brachytherapy for Radical Dose Escalation in Patients With Localized Prostate Cancer: A Longitudinal Comparative Study of 3 Historical Protocols

Combined High-Dose-Rate (HDR) Brachytherapy and External Beam Radiation Therapy (EBRT) for Prostate Cancer: 5- and 10-Year Outcomes of Protocols 1 Versus 2

PO-232 ARE URETHRAL TOXICITIES CORRELATED WITH DOSE AFTER INTERSTITIAL HDR BOOST BRACHYTHERAPY FOR PROSTATE CANCER?

Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer

PO-1036: Intraoperative HDR brachytherapy and external beam radiotherapy for prostate cancer: long-term outcomes

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer

OC-24 TEN-YEAR OUTCOMES FOR PATIENTS WITH GLEASON 8-10 TREATED WITH HIGH DOSE RATE BRACHYTHERAPY BOOST

PSMA-PET-Based Salvage By Image-Guided Adaptive HDR-Brachytherapy (HDR-IGABT) for Locally Relapsed Prostate Cancer or Stereotactic Radiation Therapy (SRT) for Distant Oligometastatic Progression – One-Year Outcomes of a Prospective Assessment in 35 Patients

Online Planned TRUS-based HDR Brachytherapy for Localized Prostate Cancer (Pca): Demonstration of a Learning Curve

PO-1033: Activation of specific anti-tumor immunity by alpha radiation based brachytherapy and immunotherapy

Cure of Triple Negative Breast Cancer Bearing Mice by Intratumoral Diffusion of Alpha-Particle Emitting Atoms in Combination with Cytoplasmic Delivery of PolyIC in a Neoadjuvant Setting

10 Year Radiotherapy Results for Prostate Cancer Patients Harboring Gleason 7-10, Stage ≥T2b, iPSA ≥20: More and Faster is Better

10-year Results in 1577 Intermediate/High Risk Prostate Cancer Patients Treated With External Beam RT (EBRT) and Hypofractionated High Dose Rate (HDR) Brachytherapy Boost

Improved 10-year Outcomes for Prostate Cancer Patients With Gleason 8–10 Treated With Intensity Modulated High Dose Rate Brachytherapy Boost in the PSA Era

2ndconservative Treatment for 2ndipsilateral Breast Tumor Event: Mature Oncological Results and Prognostic Factors from the GEC-Estro Bcwg

Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)

High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features

Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis

2009 Prevalence of erectile dysfunction in men with prostate cancer (PCa) prior to definitive radiotherapy: a prospective assessment

Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer

Suchergebnisse filtern